Synaptic regulatory update

SNAP received two U.S. patents covering serotonin receptor genes. U.S. Patent No. 5,472,866 covers the serotonin-4 receptor, a target for drugs that treat gastroesophageal reflux disease. The receptor also may be a target for drugs to treat irritable bowel syndrome. ...